Related Experiment Videos
Insights
Clinical labs aid in diagnosing myocardial infarction (MI) and screening for ischemic heart disease by assessing lipid status. Further development of specific diagnostic tests is recommended to improve MI detection.
Area of Science:
- Clinical Chemistry
- Cardiology
- Diagnostic Medicine
Background:
- Clinical laboratories provide crucial data for diagnosing myocardial infarction (MI) and screening for ischemic heart disease risk factors like hyperlipidemia.
- Lipid profiles, including serum cholesterol, triglycerides, and lipoprotein patterns, are essential for assessing ischemic heart disease risk.
Purpose of the Study:
- To review lipid panels for hyperlipidemia screening in ischemic heart disease.
- To present findings from a study of over 500 patients with chest pain, correlating clinical data with electrocardiogram, enzyme, and isoenzyme tests.
- To evaluate the diagnostic value of various laboratory tests for MI.
Main Methods:
- Review of lipid panels for hyperlipidemia assessment.
- Analysis of clinical data, electrocardiograms, enzyme tests, and isoenzyme patterns in over 500 chest pain patients.
- Comparative evaluation of diagnostic test procedures for MI.
Main Results:
- Lipid status determination is valuable for MI diagnosis and ischemic heart disease screening.
- Electrocardiogram, enzyme tests, and isoenzyme patterns, alongside clinical presentation, aid in MI diagnosis.
- Current specific indicators for MI include creatine kinase and lactate dehydrogenase isoenzyme patterns, with results available within minutes.
Conclusions:
- The diagnostic capabilities of clinical laboratories for MI can be enhanced.
- Development of new procedures with specificity equal to or greater than current isoenzyme tests is needed.
- Future approaches should aim for improved specificity and efficiency in MI diagnostics.
Abstract:
The clinical laboratory furnishes information valuable not only in the diagnosis of myocardial infarction (MI), but also in screening for possible causes of ischemic heart disease through definition of the lipid status of individuals. Accordingly, the panels used in the study of hyperlipidemia as a possible cause of ischemic heart disease are reviewed, including the determination of serum cholesterol, triglycerides, and electrophoretic development of the lipoprotein pattern. The results of an on-going study of more than 500 patients admitted to the emergency room of a general hospital with symptoms of "chest pain" are presented--including the electrocardiogram, enzyme tests, and isoenzyme patterns, in conjuction with the clinical picture. The relative diagnostic value of test procedures is considered, convering the pre-enzymatic period, current test panels, and possible future approaches. It is concluded that the laboratory's position in providing data for diagnosis of MI would be enhanced through development of procedures with as great or greater specificity than the isoenzyme patterns of creatine kinase and lactate dehydrogenase, currently the most specific indicators of MI, but which have results available in two to five minutes.